Back

A novel risk score incorporating frailty or congestion status predicted mortality in patients with heart failure with preserved ejection fraction.

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: HFpEF: data from animal studies and registries Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Katsuomi Iwakura

Sakurabashi-Watanabe Hospital, Osaka (Japan)

7 More presentations in this session

Presentation thumbnail
Identification and validation of circulating microRNAs as biomarkers for heart failure with preserved ejection fraction
Doctor L. Zhang (Zhengzhou, CN)
Abstract Slides Video
Presentation thumbnail
Role of the alarmin S100A9 in the pathogenesis of heart failure with preserved ejection fraction
Ms I. Voss (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Characterization and progression of heart failure with preserved ejection fraction in SDT fatty rats.
Doctor R. Assaly (Escalquens, FR)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of left atrial reverse remodeling in patients with ADHF-HFpEF regardless of atrial fibrillation -PURSUIT-HFpEF Registry-
Doctor T. Kondo (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Age-predicted maximal heart rate reserve as an alternative prognostic parameter in patients with heart failure with preserved ejection fraction -insights from PURSUIT-HFpEF registry-
Doctor M. Okada (Osaka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
HFpEF: data from animal studies and registries

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Three rules to find them all: clinical risk scores in heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Development and validation of a predicting model for risk of mortality in heart failure patients with mildly reduced ejection fraction post discharge
thumbnail
Congress Presentation
Frailty and cardiovascular comorbidities as predictors of short-term outcomes in HFpEF and HFmrEF patients: a retrospective cohort analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources